Vodobatinib (SCC-138)
c-Abl inhibitor for treating neurodegenerative disorders
Vodobatinib (SCO-088)
BCR ABL1 inhibitor for treating Chronic Myeloid Leukemia
SBO-154
Anti-MUC-1 ADC for treatment of solid tumours
Vibozilimod (SCD-044)
S1PR1 agonist for treating auto-immune disorders
SCD-153
Topical drug for treatment of Alopecia Areata